ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Beraprost Sodium Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-26M9706
Home | Market Reports | Health| Pharmacy
Global Beraprost Sodium Market Insights Forecast to 2028
BUY CHAPTERS

Global Beraprost Sodium Market Research Report 2025

Code: QYRE-Auto-26M9706
Report
September 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Toray
Taide Pharma
Nichiiko
Daiichi Sankyo Co Ltd
Yoshindo
Shin Poong Pharmaceutical
Ohara
TEVA
Alfresa Pharma
Lupin Laboratories
Astellas Pharma
Sawai Pharmaceutical
Viatris
Kaken Pharmaceutical
Nihon Generic Co Ltd
NABIQASIM INDUSTRIES
Kyorin Holding
KYOUSOUMIRAI PHARM

Beraprost Sodium Market Size

The global market for Beraprost Sodium was valued at US$ 120 million in the year 2024 and is projected to reach a revised size of US$ 139 million by 2031, growing at a CAGR of 2.1% during the forecast period.

Beraprost Sodium Market

Beraprost Sodium Market

Beraprost sodium (beraprost) is a stable, orally active prostacyclin analogue with vasodilatory, antiplatelet and cytoprotective effects.
The Beraprost Sodium market is driven by the rising prevalence of peripheral arterial disease (PAD) and the growing demand for effective treatment options. Beraprost Sodium is a prostacyclin analog used to improve blood flow and manage symptoms in patients with PAD, a condition characterized by reduced blood flow to the extremities. The increase in risk factors such as diabetes, smoking, and obesity contributes to market growth. The development of oral formulations of Beraprost Sodium has improved patient convenience and adherence to treatment. However, the market also faces challenges, including the need for long-term treatment and the potential for side effects in some patients. Additionally, cost considerations and reimbursement issues can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer innovative and cost-effective Beraprost Sodium formulations, collaborate with healthcare providers to improve disease management, and address the challenges to meet the increasing demand for effective PAD treatment options.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Beraprost Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beraprost Sodium.
The Beraprost Sodium market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Beraprost Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beraprost Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Beraprost Sodium Market Report

Report Metric Details
Report Name Beraprost Sodium Market
Accounted market size in year US$ 120 million
Forecasted market size in 2031 US$ 139 million
CAGR 2.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Toray, Taide Pharma, Nichiiko, Daiichi Sankyo Co Ltd, Nihon Generic Co Ltd, Yoshindo, NABIQASIM INDUSTRIES, Shin Poong Pharmaceutical, Ohara Inc, Kyorin Holding, KYOUSOUMIRAI PHARM, Teva, Alfresa Pharma, Lupin Laboratories, Astellas Pharma, Sawai Pharmaceutical, Viatris, Kaken Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Beraprost Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Beraprost Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Beraprost Sodium Market growing?

Ans: The Beraprost Sodium Market witnessing a CAGR of 2.1% during the forecast period 2025-2031.

What is the Beraprost Sodium Market size in 2031?

Ans: The Beraprost Sodium Market size in 2031 will be US$ 139 million.

Who are the main players in the Beraprost Sodium Market report?

Ans: The main players in the Beraprost Sodium Market are Toray, Taide Pharma, Nichiiko, Daiichi Sankyo Co Ltd, Nihon Generic Co Ltd, Yoshindo, NABIQASIM INDUSTRIES, Shin Poong Pharmaceutical, Ohara Inc, Kyorin Holding, KYOUSOUMIRAI PHARM, Teva, Alfresa Pharma, Lupin Laboratories, Astellas Pharma, Sawai Pharmaceutical, Viatris, Kaken Pharmaceutical

What are the Application segmentation covered in the Beraprost Sodium Market report?

Ans: The Applications covered in the Beraprost Sodium Market report are Hospital, Clinic

What are the Type segmentation covered in the Beraprost Sodium Market report?

Ans: The Types covered in the Beraprost Sodium Market report are Tablet, Sustained Release Tablets

Recommended Reports

Sodium-Based APIs

Sodium Injectables

Cardiovascular Therapies

1 Beraprost Sodium Market Overview
1.1 Product Definition
1.2 Beraprost Sodium by Type
1.2.1 Global Beraprost Sodium Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Sustained Release Tablets
1.3 Beraprost Sodium by Application
1.3.1 Global Beraprost Sodium Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Beraprost Sodium Market Size Estimates and Forecasts
1.4.1 Global Beraprost Sodium Revenue 2020-2031
1.4.2 Global Beraprost Sodium Sales 2020-2031
1.4.3 Global Beraprost Sodium Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Beraprost Sodium Market Competition by Manufacturers
2.1 Global Beraprost Sodium Sales Market Share by Manufacturers (2020-2025)
2.2 Global Beraprost Sodium Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Beraprost Sodium Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Beraprost Sodium, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Beraprost Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Beraprost Sodium, Product Type & Application
2.7 Global Key Manufacturers of Beraprost Sodium, Date of Enter into This Industry
2.8 Global Beraprost Sodium Market Competitive Situation and Trends
2.8.1 Global Beraprost Sodium Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Beraprost Sodium Players Market Share by Revenue
2.8.3 Global Beraprost Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Beraprost Sodium Market Scenario by Region
3.1 Global Beraprost Sodium Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Beraprost Sodium Sales by Region: 2020-2031
3.2.1 Global Beraprost Sodium Sales by Region: 2020-2025
3.2.2 Global Beraprost Sodium Sales by Region: 2026-2031
3.3 Global Beraprost Sodium Revenue by Region: 2020-2031
3.3.1 Global Beraprost Sodium Revenue by Region: 2020-2025
3.3.2 Global Beraprost Sodium Revenue by Region: 2026-2031
3.4 North America Beraprost Sodium Market Facts & Figures by Country
3.4.1 North America Beraprost Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Beraprost Sodium Sales by Country (2020-2031)
3.4.3 North America Beraprost Sodium Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Beraprost Sodium Market Facts & Figures by Country
3.5.1 Europe Beraprost Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Beraprost Sodium Sales by Country (2020-2031)
3.5.3 Europe Beraprost Sodium Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Beraprost Sodium Market Facts & Figures by Region
3.6.1 Asia Pacific Beraprost Sodium Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Beraprost Sodium Sales by Region (2020-2031)
3.6.3 Asia Pacific Beraprost Sodium Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Beraprost Sodium Market Facts & Figures by Country
3.7.1 Latin America Beraprost Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Beraprost Sodium Sales by Country (2020-2031)
3.7.3 Latin America Beraprost Sodium Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Beraprost Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Beraprost Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Beraprost Sodium Sales by Country (2020-2031)
3.8.3 Middle East and Africa Beraprost Sodium Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Beraprost Sodium Sales by Type (2020-2031)
4.1.1 Global Beraprost Sodium Sales by Type (2020-2025)
4.1.2 Global Beraprost Sodium Sales by Type (2026-2031)
4.1.3 Global Beraprost Sodium Sales Market Share by Type (2020-2031)
4.2 Global Beraprost Sodium Revenue by Type (2020-2031)
4.2.1 Global Beraprost Sodium Revenue by Type (2020-2025)
4.2.2 Global Beraprost Sodium Revenue by Type (2026-2031)
4.2.3 Global Beraprost Sodium Revenue Market Share by Type (2020-2031)
4.3 Global Beraprost Sodium Price by Type (2020-2031)
5 Segment by Application
5.1 Global Beraprost Sodium Sales by Application (2020-2031)
5.1.1 Global Beraprost Sodium Sales by Application (2020-2025)
5.1.2 Global Beraprost Sodium Sales by Application (2026-2031)
5.1.3 Global Beraprost Sodium Sales Market Share by Application (2020-2031)
5.2 Global Beraprost Sodium Revenue by Application (2020-2031)
5.2.1 Global Beraprost Sodium Revenue by Application (2020-2025)
5.2.2 Global Beraprost Sodium Revenue by Application (2026-2031)
5.2.3 Global Beraprost Sodium Revenue Market Share by Application (2020-2031)
5.3 Global Beraprost Sodium Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Toray
6.1.1 Toray Company Information
6.1.2 Toray Description and Business Overview
6.1.3 Toray Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Toray Beraprost Sodium Product Portfolio
6.1.5 Toray Recent Developments/Updates
6.2 Taide Pharma
6.2.1 Taide Pharma Company Information
6.2.2 Taide Pharma Description and Business Overview
6.2.3 Taide Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Taide Pharma Beraprost Sodium Product Portfolio
6.2.5 Taide Pharma Recent Developments/Updates
6.3 Nichiiko
6.3.1 Nichiiko Company Information
6.3.2 Nichiiko Description and Business Overview
6.3.3 Nichiiko Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nichiiko Beraprost Sodium Product Portfolio
6.3.5 Nichiiko Recent Developments/Updates
6.4 Daiichi Sankyo Co Ltd
6.4.1 Daiichi Sankyo Co Ltd Company Information
6.4.2 Daiichi Sankyo Co Ltd Description and Business Overview
6.4.3 Daiichi Sankyo Co Ltd Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolio
6.4.5 Daiichi Sankyo Co Ltd Recent Developments/Updates
6.5 Nihon Generic Co Ltd
6.5.1 Nihon Generic Co Ltd Company Information
6.5.2 Nihon Generic Co Ltd Description and Business Overview
6.5.3 Nihon Generic Co Ltd Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nihon Generic Co Ltd Beraprost Sodium Product Portfolio
6.5.5 Nihon Generic Co Ltd Recent Developments/Updates
6.6 Yoshindo
6.6.1 Yoshindo Company Information
6.6.2 Yoshindo Description and Business Overview
6.6.3 Yoshindo Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Yoshindo Beraprost Sodium Product Portfolio
6.6.5 Yoshindo Recent Developments/Updates
6.7 NABIQASIM INDUSTRIES
6.7.1 NABIQASIM INDUSTRIES Company Information
6.7.2 NABIQASIM INDUSTRIES Description and Business Overview
6.7.3 NABIQASIM INDUSTRIES Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolio
6.7.5 NABIQASIM INDUSTRIES Recent Developments/Updates
6.8 Shin Poong Pharmaceutical
6.8.1 Shin Poong Pharmaceutical Company Information
6.8.2 Shin Poong Pharmaceutical Description and Business Overview
6.8.3 Shin Poong Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shin Poong Pharmaceutical Beraprost Sodium Product Portfolio
6.8.5 Shin Poong Pharmaceutical Recent Developments/Updates
6.9 Ohara Inc
6.9.1 Ohara Inc Company Information
6.9.2 Ohara Inc Description and Business Overview
6.9.3 Ohara Inc Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ohara Inc Beraprost Sodium Product Portfolio
6.9.5 Ohara Inc Recent Developments/Updates
6.10 Kyorin Holding
6.10.1 Kyorin Holding Company Information
6.10.2 Kyorin Holding Description and Business Overview
6.10.3 Kyorin Holding Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Kyorin Holding Beraprost Sodium Product Portfolio
6.10.5 Kyorin Holding Recent Developments/Updates
6.11 KYOUSOUMIRAI PHARM
6.11.1 KYOUSOUMIRAI PHARM Company Information
6.11.2 KYOUSOUMIRAI PHARM Description and Business Overview
6.11.3 KYOUSOUMIRAI PHARM Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.11.4 KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolio
6.11.5 KYOUSOUMIRAI PHARM Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Teva Beraprost Sodium Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Alfresa Pharma
6.13.1 Alfresa Pharma Company Information
6.13.2 Alfresa Pharma Description and Business Overview
6.13.3 Alfresa Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Alfresa Pharma Beraprost Sodium Product Portfolio
6.13.5 Alfresa Pharma Recent Developments/Updates
6.14 Lupin Laboratories
6.14.1 Lupin Laboratories Company Information
6.14.2 Lupin Laboratories Description and Business Overview
6.14.3 Lupin Laboratories Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Lupin Laboratories Beraprost Sodium Product Portfolio
6.14.5 Lupin Laboratories Recent Developments/Updates
6.15 Astellas Pharma
6.15.1 Astellas Pharma Company Information
6.15.2 Astellas Pharma Description and Business Overview
6.15.3 Astellas Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Astellas Pharma Beraprost Sodium Product Portfolio
6.15.5 Astellas Pharma Recent Developments/Updates
6.16 Sawai Pharmaceutical
6.16.1 Sawai Pharmaceutical Company Information
6.16.2 Sawai Pharmaceutical Description and Business Overview
6.16.3 Sawai Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Sawai Pharmaceutical Beraprost Sodium Product Portfolio
6.16.5 Sawai Pharmaceutical Recent Developments/Updates
6.17 Viatris
6.17.1 Viatris Company Information
6.17.2 Viatris Description and Business Overview
6.17.3 Viatris Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Viatris Beraprost Sodium Product Portfolio
6.17.5 Viatris Recent Developments/Updates
6.18 Kaken Pharmaceutical
6.18.1 Kaken Pharmaceutical Company Information
6.18.2 Kaken Pharmaceutical Description and Business Overview
6.18.3 Kaken Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Kaken Pharmaceutical Beraprost Sodium Product Portfolio
6.18.5 Kaken Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Beraprost Sodium Industry Chain Analysis
7.2 Beraprost Sodium Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Beraprost Sodium Production Mode & Process Analysis
7.4 Beraprost Sodium Sales and Marketing
7.4.1 Beraprost Sodium Sales Channels
7.4.2 Beraprost Sodium Distributors
7.5 Beraprost Sodium Customer Analysis
8 Beraprost Sodium Market Dynamics
8.1 Beraprost Sodium Industry Trends
8.2 Beraprost Sodium Market Drivers
8.3 Beraprost Sodium Market Challenges
8.4 Beraprost Sodium Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Toray
Taide Pharma
Nichiiko
Daiichi Sankyo Co Ltd
Yoshindo
Shin Poong Pharmaceutical
Ohara
TEVA
Alfresa Pharma
Lupin Laboratories
Astellas Pharma
Sawai Pharmaceutical
Viatris
Kaken Pharmaceutical
Nihon Generic Co Ltd
NABIQASIM INDUSTRIES
Kyorin Holding
KYOUSOUMIRAI PHARM
List of Tables
 Table 1. Global Beraprost Sodium Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Beraprost Sodium Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Beraprost Sodium Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Beraprost Sodium Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Beraprost Sodium Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Beraprost Sodium Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Beraprost Sodium Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Beraprost Sodium Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Beraprost Sodium, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Beraprost Sodium, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Beraprost Sodium, Product Type & Application
 Table 12. Global Key Manufacturers of Beraprost Sodium, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Beraprost Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beraprost Sodium as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Beraprost Sodium Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Beraprost Sodium Sales by Region (2020-2025) & (K Units)
 Table 18. Global Beraprost Sodium Sales Market Share by Region (2020-2025)
 Table 19. Global Beraprost Sodium Sales by Region (2026-2031) & (K Units)
 Table 20. Global Beraprost Sodium Sales Market Share by Region (2026-2031)
 Table 21. Global Beraprost Sodium Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Beraprost Sodium Revenue Market Share by Region (2020-2025)
 Table 23. Global Beraprost Sodium Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Beraprost Sodium Revenue Market Share by Region (2026-2031)
 Table 25. North America Beraprost Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Beraprost Sodium Sales by Country (2020-2025) & (K Units)
 Table 27. North America Beraprost Sodium Sales by Country (2026-2031) & (K Units)
 Table 28. North America Beraprost Sodium Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Beraprost Sodium Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Beraprost Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Beraprost Sodium Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Beraprost Sodium Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Beraprost Sodium Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Beraprost Sodium Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Beraprost Sodium Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Beraprost Sodium Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Beraprost Sodium Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Beraprost Sodium Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Beraprost Sodium Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Beraprost Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Beraprost Sodium Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Beraprost Sodium Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Beraprost Sodium Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Beraprost Sodium Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Beraprost Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Beraprost Sodium Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Beraprost Sodium Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Beraprost Sodium Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Beraprost Sodium Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Beraprost Sodium Sales (K Units) by Type (2020-2025)
 Table 51. Global Beraprost Sodium Sales (K Units) by Type (2026-2031)
 Table 52. Global Beraprost Sodium Sales Market Share by Type (2020-2025)
 Table 53. Global Beraprost Sodium Sales Market Share by Type (2026-2031)
 Table 54. Global Beraprost Sodium Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Beraprost Sodium Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Beraprost Sodium Revenue Market Share by Type (2020-2025)
 Table 57. Global Beraprost Sodium Revenue Market Share by Type (2026-2031)
 Table 58. Global Beraprost Sodium Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Beraprost Sodium Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Beraprost Sodium Sales (K Units) by Application (2020-2025)
 Table 61. Global Beraprost Sodium Sales (K Units) by Application (2026-2031)
 Table 62. Global Beraprost Sodium Sales Market Share by Application (2020-2025)
 Table 63. Global Beraprost Sodium Sales Market Share by Application (2026-2031)
 Table 64. Global Beraprost Sodium Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Beraprost Sodium Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Beraprost Sodium Revenue Market Share by Application (2020-2025)
 Table 67. Global Beraprost Sodium Revenue Market Share by Application (2026-2031)
 Table 68. Global Beraprost Sodium Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Beraprost Sodium Price (USD/Unit) by Application (2026-2031)
 Table 70. Toray Company Information
 Table 71. Toray Description and Business Overview
 Table 72. Toray Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Toray Beraprost Sodium Product
 Table 74. Toray Recent Developments/Updates
 Table 75. Taide Pharma Company Information
 Table 76. Taide Pharma Description and Business Overview
 Table 77. Taide Pharma Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Taide Pharma Beraprost Sodium Product
 Table 79. Taide Pharma Recent Developments/Updates
 Table 80. Nichiiko Company Information
 Table 81. Nichiiko Description and Business Overview
 Table 82. Nichiiko Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Nichiiko Beraprost Sodium Product
 Table 84. Nichiiko Recent Developments/Updates
 Table 85. Daiichi Sankyo Co Ltd Company Information
 Table 86. Daiichi Sankyo Co Ltd Description and Business Overview
 Table 87. Daiichi Sankyo Co Ltd Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Daiichi Sankyo Co Ltd Beraprost Sodium Product
 Table 89. Daiichi Sankyo Co Ltd Recent Developments/Updates
 Table 90. Nihon Generic Co Ltd Company Information
 Table 91. Nihon Generic Co Ltd Description and Business Overview
 Table 92. Nihon Generic Co Ltd Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Nihon Generic Co Ltd Beraprost Sodium Product
 Table 94. Nihon Generic Co Ltd Recent Developments/Updates
 Table 95. Yoshindo Company Information
 Table 96. Yoshindo Description and Business Overview
 Table 97. Yoshindo Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Yoshindo Beraprost Sodium Product
 Table 99. Yoshindo Recent Developments/Updates
 Table 100. NABIQASIM INDUSTRIES Company Information
 Table 101. NABIQASIM INDUSTRIES Description and Business Overview
 Table 102. NABIQASIM INDUSTRIES Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. NABIQASIM INDUSTRIES Beraprost Sodium Product
 Table 104. NABIQASIM INDUSTRIES Recent Developments/Updates
 Table 105. Shin Poong Pharmaceutical Company Information
 Table 106. Shin Poong Pharmaceutical Description and Business Overview
 Table 107. Shin Poong Pharmaceutical Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Shin Poong Pharmaceutical Beraprost Sodium Product
 Table 109. Shin Poong Pharmaceutical Recent Developments/Updates
 Table 110. Ohara Inc Company Information
 Table 111. Ohara Inc Description and Business Overview
 Table 112. Ohara Inc Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Ohara Inc Beraprost Sodium Product
 Table 114. Ohara Inc Recent Developments/Updates
 Table 115. Kyorin Holding Company Information
 Table 116. Kyorin Holding Description and Business Overview
 Table 117. Kyorin Holding Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Kyorin Holding Beraprost Sodium Product
 Table 119. Kyorin Holding Recent Developments/Updates
 Table 120. KYOUSOUMIRAI PHARM Company Information
 Table 121. KYOUSOUMIRAI PHARM Description and Business Overview
 Table 122. KYOUSOUMIRAI PHARM Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. KYOUSOUMIRAI PHARM Beraprost Sodium Product
 Table 124. KYOUSOUMIRAI PHARM Recent Developments/Updates
 Table 125. Teva Company Information
 Table 126. Teva Description and Business Overview
 Table 127. Teva Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Teva Beraprost Sodium Product
 Table 129. Teva Recent Developments/Updates
 Table 130. Alfresa Pharma Company Information
 Table 131. Alfresa Pharma Description and Business Overview
 Table 132. Alfresa Pharma Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Alfresa Pharma Beraprost Sodium Product
 Table 134. Alfresa Pharma Recent Developments/Updates
 Table 135. Lupin Laboratories Company Information
 Table 136. Lupin Laboratories Description and Business Overview
 Table 137. Lupin Laboratories Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Lupin Laboratories Beraprost Sodium Product
 Table 139. Lupin Laboratories Recent Developments/Updates
 Table 140. Astellas Pharma Company Information
 Table 141. Astellas Pharma Description and Business Overview
 Table 142. Astellas Pharma Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Astellas Pharma Beraprost Sodium Product
 Table 144. Astellas Pharma Recent Developments/Updates
 Table 145. Sawai Pharmaceutical Company Information
 Table 146. Sawai Pharmaceutical Description and Business Overview
 Table 147. Sawai Pharmaceutical Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Sawai Pharmaceutical Beraprost Sodium Product
 Table 149. Sawai Pharmaceutical Recent Developments/Updates
 Table 150. Viatris Company Information
 Table 151. Viatris Description and Business Overview
 Table 152. Viatris Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Viatris Beraprost Sodium Product
 Table 154. Viatris Recent Developments/Updates
 Table 155. Kaken Pharmaceutical Company Information
 Table 156. Kaken Pharmaceutical Description and Business Overview
 Table 157. Kaken Pharmaceutical Beraprost Sodium Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. Kaken Pharmaceutical Beraprost Sodium Product
 Table 159. Kaken Pharmaceutical Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Beraprost Sodium Distributors List
 Table 163. Beraprost Sodium Customers List
 Table 164. Beraprost Sodium Market Trends
 Table 165. Beraprost Sodium Market Drivers
 Table 166. Beraprost Sodium Market Challenges
 Table 167. Beraprost Sodium Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Beraprost Sodium
 Figure 2. Global Beraprost Sodium Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Beraprost Sodium Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Sustained Release Tablets Product Picture
 Figure 6. Global Beraprost Sodium Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Beraprost Sodium Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Beraprost Sodium Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Beraprost Sodium Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Beraprost Sodium Sales (2020-2031) & (K Units)
 Figure 13. Global Beraprost Sodium Average Price (USD/Unit) & (2020-2031)
 Figure 14. Beraprost Sodium Report Years Considered
 Figure 15. Beraprost Sodium Sales Share by Manufacturers in 2024
 Figure 16. Global Beraprost Sodium Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Beraprost Sodium Players: Market Share by Revenue in Beraprost Sodium in 2024
 Figure 18. Beraprost Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Beraprost Sodium Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Beraprost Sodium Sales Market Share by Country (2020-2031)
 Figure 21. North America Beraprost Sodium Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Beraprost Sodium Sales Market Share by Country (2020-2031)
 Figure 25. Europe Beraprost Sodium Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Beraprost Sodium Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Beraprost Sodium Revenue Market Share by Region (2020-2031)
 Figure 33. China Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Beraprost Sodium Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Beraprost Sodium Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Beraprost Sodium Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Beraprost Sodium Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Beraprost Sodium by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Beraprost Sodium by Type (2020-2031)
 Figure 55. Global Beraprost Sodium Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Beraprost Sodium by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Beraprost Sodium by Application (2020-2031)
 Figure 58. Global Beraprost Sodium Price (USD/Unit) by Application (2020-2031)
 Figure 59. Beraprost Sodium Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Beraprost Market Research Report 2024
Global Beraprost Sodium Tablets Market Research Report 2024
Global Epoprostenol Sodium Drugs Market Insights Forecast to 2030
Global Epoprostenol Sodium Market Insights Forecast to 2030
Global D Cloprostenol Sodium Market Research Report 2024
Global Treprostinil Market Insights Forecast to 2030
Global Treprostinil Sodium Market Research Report 2025
Global Treprostinil Drugs Market Insights Forecast to 2030
Global Epoprostenol Sodium FDF Market Insights Forecast to 2030
Global Cloprostenol Sodium Market Research Report 2025
Global Cloprostenol Sodium Salt Market Research Report 2024
Global Bovine Heparin Sodium Market Research Report 2025
Global Amlodipine Besylate Capsule Market Research Report 2025
Global Spironolactone API Market Research Report 2025
Global Tafluprost Market Insights Forecast to 2030
Global Cloprostenol Sodium Salt Reagent Market Research Report 2024
Global Noproxen Market Insights Forecast to 2030
Global Fosinopril Sodium Tablets Market Research Report 2024
Global Pravastatin Sodium Tablets Market Research Report 2024
Methotrexate Sodium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions